STAT
NOVEMBER 27, 2024
WASHINGTON — Legislation targeting Chinese biotechnology companies caused a ruckus early this year. None of that may matter if Congress doesn’t pass it in December. The BIOSECURE Act would restrict U.S. pharmaceutical and biotechnology companies from doing business with certain Chinese companies, including WuXi AppTec and WuXi Biologics.
Drug Topics
NOVEMBER 27, 2024
A recent study found that there was a significant relationship between self-efficacy for disease control and the level of glycemic control.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
NOVEMBER 27, 2024
In trials, blood pressure reductions were maintained over extended periods, suggesting that the drug could offer a sustained effect.
Drug Topics
NOVEMBER 27, 2024
Researchers explored the disease activity of patients with axial spondylarthritis after various modifications to their diets.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
NOVEMBER 27, 2024
Methemoglobinemia is a blood disorder that affects proper release of oxygen around the body.
PharmaVoice
NOVEMBER 27, 2024
Lindus Health’s women-focused CRO is the latest in a handful of research efforts to target specialized — and underrepresented — populations.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmaceutical Technology
NOVEMBER 27, 2024
Pharmaceutical professionals expect digital solutions to solve drug development headaches, with AI already proving disruptive.
Pharmacy Times
NOVEMBER 27, 2024
However, pharmacists can help mitigate these effects.
pharmaphorum
NOVEMBER 27, 2024
Learn how AI can accelerate the Medical, Legal, and Regulatory (MLR) review process. Discover strategies for leveraging AI to streamline and optimise MLR review in the medical, legal, and regulatory fields.
Pharmacy Times
NOVEMBER 27, 2024
The approval is based on clinical studies that demonstrate the management of heart rate with minimal reductions to blood pressure.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Technology
NOVEMBER 27, 2024
In recent years, the evolution of biologic therapies for severe asthma has paralleled advancements in other chronic conditions such as rheumatoid arthritis and psoriasis, where biologics have also transformed treatment paradigms.
Pharmacy Times
NOVEMBER 27, 2024
Trends across small cell lung cancer (SCLC) and diffuse large B-cell lymphoma (DLBCL) emphasize the need to further improve global treatment options.
Fierce Pharma
NOVEMBER 27, 2024
The competition among three TROP2 antibody-drug conjugates is ent | The competition among three TROP2 antibody-drug conjugates is entering a new stage as Kelun-Biotech’s Merck & Co.-partnered sacituzumab tirumotecan has become the second therapy in the class to win a marketing approval.
Pharmacy Times
NOVEMBER 27, 2024
Evidence suggests that precautionary measures in elementary schools were able to effectively mitigate large increases in disease transmission.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmig
NOVEMBER 27, 2024
Hand washing, disinfection, and gloves are critical elements of hand hygiene in pharmaceutical microbiology. Read more about the best practices online here. The post A Quick Guide To Hand Hygiene Best Practices appeared first on Pharmig.
Pharmacy Times
NOVEMBER 27, 2024
The proposed rule would increase access to semaglutide for millions of Americans.
Fierce Pharma
NOVEMBER 27, 2024
Before Exelexis’ Cabometyx can pass muster with the FDA in its hopeful neuroendocrine tumors indication next April, it will have to first face the agency’s Oncologic Drugs Advisory Committee ( | The agency's Oncologic Drugs Advisory Committee is set to discuss the treatment and its phase 3 CABINET study in March ahead of the FDA's planned decision date of April 2025.
Pharmacy Times
NOVEMBER 27, 2024
These findings are significant in understanding interactions between glucagon-like peptide-1 medications and thyroid dysfunction because prior research has shown conflicting results.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Pharma
NOVEMBER 27, 2024
Once a controversial European depression treatment that never made it to the U.S. | The treatment, which was once a Pfizer antidepressant, reduced bouts of cataplexy and other narcolepsy symptoms in Axsome's ENCORE study.
Pharmacy Times
NOVEMBER 27, 2024
Because these cells are present throughout the body, there may also be implications for other cancer types.
Fierce Pharma
NOVEMBER 27, 2024
Two months after Sanofi completed construction in France of its innovative Modulus vaccine and biologics plant—which can be reconfigured within days during a pandemic—the drugmaker said it has
Fierce Healthcare
NOVEMBER 27, 2024
Health policy staffers gathered last week at the Capitol for a day of discussing AI policy with members of industry, hosted by the Coalition for Health AI (CHAI), a non-profit AI advocacy | This comes as the president-elect reportedly seeks to hire an “AI Czar” to spearhead progress for the technology under his administration, per Axios.
pharmaphorum
NOVEMBER 27, 2024
AstraZeneca and Ionis' Wainzua has been recommended for NHS use in the treatment of patients with ATTR polyneuropathy
Fierce Healthcare
NOVEMBER 27, 2024
LAS VEGAS — CVS' home health arm Signify Health is set to make 3.3 million home visits this year, and the team isn't looking to stop there. | CVS' home health arm Signify Health is set to make 3.3 million home visits this year, and the team isn't looking to stop there.
Pharmacy Times
NOVEMBER 27, 2024
Lisocabtagene maraleucel chimeric antigen receptor T-cell therapy significantly enhances treatment of relapsed/refractory B-cell malignancies, offering high response rates and durable remissions.
Fierce Healthcare
NOVEMBER 27, 2024
Just three years ago, primary care was a hot category with major players making sizeable investments to build out healthcare businesses. | Forward, with its focus on technology and AI-enabled CarePods, was “ahead of its time,” founder Adrian Aoun said on the More or Less from the Morins and the Lessins podcast.
Pharmaceutical Technology
NOVEMBER 27, 2024
In an advancement for diabetes management, the US Food and Drug Administration (FDA) has granted clearance to Medtronic’s new InPen app, setting the stage for the launch of the company’s Smart MDI system integrated with the Simplera continuous glucose monitor (CGM).
The Happy PharmD
NOVEMBER 27, 2024
Krogers pharmacy story is a tale of ambition colliding with harsh realities, leaving both pharmacists and patients grappling with its fallout. With over 2,200 pharmacies spread across 35 states, Kroger has become a household name, not just for groceries but for healthcare. Yet behind the counters, the smiles often mask a brewing storm overworked staff, customer dissatisfaction, and a growing list of challenges.
Hospital Pharmacy Europe
NOVEMBER 27, 2024
Three models of clinical supervision were explored at the Royal Pharmaceutical Society (RPS) conference earlier this month, in a session chaired by Susan Roberts, the associate director for pharmacy at NHS Education for Scotland. The session was badged as ‘The great prescribing debate’ and heard about approaches being used to support pharmacists to develop into confident and safe prescribers.
Pharmaceutical Commerce
NOVEMBER 27, 2024
Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.
Pharmaceutical Technology
NOVEMBER 27, 2024
Discover the leading lead generation providers and technology solutions tailored for the pharmaceutical industry. Download our guide for industry insights and technology solution information.
PharmExec
NOVEMBER 27, 2024
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
NOVEMBER 27, 2024
With expected sales for GLP1Rs in obesity estimated to surpass $126 billion by 2030, this drug category presents a lucrative market.
Expert insights. Personalized for you.
130 
Let's personalize your content